Bruce Spiegelman, Dana-Farber Cancer Institute, USA
Bruce M. Spiegelman is the Stanley J. Korsmeyer Professor at Harvard Medical School and Dana-Farber Cancer Institute. Spiegelman received a B.S. with highest honors from the College of William and Mary in 1974, his PhD in biochemistry from Princeton University in 1978, and completed postdoctoral work at MIT. He joined Harvard Medical School and Dana-Farber Cancer Institute in 1982 and was appointed Professor in 1991. His research focuses on fat cell biology, diabetes andmuscular diseases. Spiegelman’s accomplishments have been recognized by the awarding of a number of honors and prizes. Major honors include: the Heinrich Wieland Prize in Lipid Research (University of Munich, 1997); the Bristol-Myers Squibb Award for Distinguished Achievement in Metabolic Research (2003); the Rolf Luft Prize in Metabolic Research (Karolinska Institute, 2003); the Jacobaeus Prize (Novo-Nordisk, 2004); the Eliot P. Joslin Medal (Joslin Diabetes Center, 2004); the Transatlantic Medal (British Endocrine Society, 2007); the Debrecen Prize (Faculty of Medicine, Debrecen, Hungary, 2008); the Naomi Berrie Award for Outstanding Achievement in Diabetes Research (Columbia University Medical Center, 2008); the Hans Bloemendal Medal for Outstanding Scientific Achievement (Radboud University Nijmegen Medical Centre, The Netherlands, 2010); the Frederick Banting Medal of the American Diabetes Association (their highest award) in 2012; the Manpei Suzuki Prize for Diabetes Research (Tokyo) in 2013, the Inbev Baillet-Latour Health Prize in 2015 and Helmholtz Prize for Diabetes Research, Munich, Germany, 2015.
Spiegelman has also been elected to the National Academy of Sciences and the American Academy of Arts and Sciences, both in 2002. He was also elected to the Institute of Medicine of the USA in 2014. He has served as the elected Chair of the Section on Metabolism and Medical Physiology of the National Academy of Sciences (2013-2016).
« Go Back